SCHEMBL20243152

SCHEMBL20243152

Nc1ncc(-c2cccc(Cl)c2)o1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCP P55072 1/20 0.52
TDO2 P48775 1/20 0.49
DHFR P00374 1/20 0.47
FFAR1 O14842 1/20 0.45
NPC1 O15118 1/20 0.45
TP53 P04637 1/20 0.45
TSHR P16473 1/20 0.45
NFKB1 P19838 1/20 0.45
RAB9A P51151 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
CLK1 P49759 1/20 0.44
IDO1 P14902 1/20 0.44
SLC9A1 P19634 1/20 0.43
MAP4K4 O95819 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14650182 0.82 MAP4K4 (0.54) NPC1RAB9AMAP4K4MEN1KMT2A
SCHEMBL23539672 0.82 VCP (0.55) VCPTDO2DHFRFFAR1NPC1
SCHEMBL30041533 0.82 VCP (0.55) VCPTDO2DHFRFFAR1NPC1
SCHEMBL11619630 0.82 FFAR1 (0.51) VCPTDO2DHFRFFAR1NPC1
SCHEMBL4528767 0.81 RAB9A (0.47) NPC1TP53TSHRNFKB1RAB9A
SCHEMBL20600253 0.80 FFAR1 (0.52) VCPTDO2FFAR1NPC1TP53
SCHEMBL29393846 0.80 FFAR1 (0.52) VCPTDO2FFAR1NPC1TP53
SCHEMBL4537426 0.80 RAB9A (0.54) TDO2DHFRNPC1TP53RAB9A
SCHEMBL1544316 0.79 VCP (0.52) VCPFFAR1NPC1TP53TSHR
SCHEMBL20242220 0.79 TAAR1 (0.46) FFAR1IDO1SLC9A1MAP4K4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018106643-A1 HETEROCYCLIC AZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-06-14 WO disclosed